ABCL
AbCellera Biologics (ABCL) Earnings
Review AbCellera Biologics (ABCL) earnings with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Annual EPS
- -0.49
- Trailing EPS
- -0.54
- Annual revenue
- $75.13M
- Trailing revenue
- $66.17M
- Next earnings date
- 2026-08-05
- Earnings data source
- MarketBeat historical revenue consensus + S&P Global consensus via StockAnalysis + Finnhub earnings
AbCellera Biologics (ABCL) Earnings research
The ABCL earnings page organizes the available earnings-per-share and revenue context for AbCellera Biologics. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.
Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.